GM Advisory Group LLC Invests $482,000 in Tempus AI, Inc. $TEM

Key Points

• GM Advisory Group LLC has invested approximately $482,000 in Tempus AI, acquiring 10,000 shares during the first quarter.
• Tempus AI has seen various institutional investors, including First Horizon Advisors and Wells Fargo, adjust their stakes in the company, increasing investor ownership to 24.22%.
• Analysts maintain a consensus of "Moderate Buy" for Tempus AI, with price targets ranging from $68.00 to $85.00, reflecting expectations for continued growth.

GM Advisory Group LLC bought a new position in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor bought 10,000 shares of the company's stock, valued at approximately $482,000.

Several other large investors have also made changes to their positions in TEM. Vanguard Group Inc. raised its stake in shares of Tempus AI by 6,247.5% during the 1st quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company's stock worth $289,204,000 after buying an additional 5,900,668 shares during the period. ARK Investment Management LLC raised its stake in Tempus AI by 35.9% in the 1st quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company's stock valued at $361,867,000 after purchasing an additional 1,981,755 shares during the last quarter. Nikko Asset Management Americas Inc. raised its stake in Tempus AI by 31.5% in the 1st quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company's stock valued at $205,401,000 after purchasing an additional 1,021,460 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. raised its stake in Tempus AI by 31.4% in the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock valued at $205,284,000 after purchasing an additional 1,016,384 shares during the last quarter. Finally, CloudAlpha Capital Management Limited Hong Kong acquired a new position in Tempus AI in the 1st quarter valued at $34,119,000. 24.22% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

TEM has been the subject of several recent research reports. Morgan Stanley increased their price objective on Tempus AI from $65.00 to $68.00 and gave the company an "overweight" rating in a research note on Tuesday, August 12th. Bank of America increased their price objective on Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a research note on Wednesday, June 25th. Piper Sandler reissued a "neutral" rating on shares of Tempus AI in a research note on Friday, August 8th. Needham & Company LLC reaffirmed a "buy" rating and issued a $70.00 target price on shares of Tempus AI in a research note on Friday, August 8th. Finally, Guggenheim raised their target price on Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a research note on Monday, June 30th. Six research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $67.64.

Tempus AI Trading Up 5.0%

Shares of TEM traded up $3.81 during midday trading on Friday, reaching $80.52. The company had a trading volume of 18,631,489 shares, compared to its average volume of 11,534,770. Tempus AI, Inc. has a 1-year low of $31.36 and a 1-year high of $91.45. The stock has a market cap of $13.99 billion, a PE ratio of -67.66 and a beta of 4.98. The firm has a 50 day simple moving average of $63.78 and a 200-day simple moving average of $59.21. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.58.

Tempus AI (NASDAQ:TEM - Get Free Report) last issued its earnings results on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.23) by $0.01. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The business had revenue of $314.64 million during the quarter, compared to the consensus estimate of $296.84 million. During the same period last year, the company earned ($6.86) EPS. The company's revenue for the quarter was up 89.5% on a year-over-year basis. Tempus AI has set its FY 2025 guidance at EPS. Research analysts forecast that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Insider Buying and Selling at Tempus AI

In other news, CFO James William Rogers sold 7,528 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $561,965.20. Following the completion of the transaction, the chief financial officer directly owned 138,473 shares in the company, valued at approximately $10,337,009.45. This represents a 5.16% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Theodore Leonsis sold 205,847 shares of the stock in a transaction on Wednesday, June 11th. The stock was sold at an average price of $67.66, for a total value of $13,927,608.02. Following the transaction, the director owned 15,511 shares of the company's stock, valued at approximately $1,049,474.26. This represents a 92.99% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 776,451 shares of company stock worth $53,022,688. Insiders own 27.60% of the company's stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.